Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Ref Type | |||||||||||||
PMID | |||||||||||||
Authors | Do-Youn Oh, Jaffer A. Ajani, Yung-Jue Bang, Hyun Cheol Chung, Jill Lacy, Jeeyun Lee, Teresa Macarulla, Gulam Abbas Manji, Eileen Mary O'Reilly, Simon Allen, Nedal Jaffer Abdulla Al-Sakaff, Hila Barak, Jilpa Patel, Jan Peter Pintoffl, Colby Shemesh, Wei Zhang, Xiaosong Zhang, Ian Chau | ||||||||||||
Title | Phase Ib/II open-label, randomized evaluation of 2L atezolizumab (atezo) + BL-8040 versus control in MORPHEUS-pancreatic ductal adenocarcinoma (M-PDAC) and MORPHEUS-gastric cancer (M-GC). | ||||||||||||
|
|||||||||||||
URL | https://meetinglibrary.asco.org/record/182226/abstract | ||||||||||||
Abstract Text | J Clin Oncol 38, 2020 (suppl 4; abstr 712) |
Molecular Profile | Treatment Approach |
---|
Gene Name | Source | Synonyms | Protein Domains | Gene Description | Gene Role |
---|
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|
Gene | Variant | Impact | Protein Effect | Variant Description | Associated with drug Resistance |
---|
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|